The microbiota of the respiratory tract: Gatekeeper to respiratory health

Nature Reviews Microbiology

Volumn 15, Issue 5, 2017, Pages 259-270

  Man, Wing Ho ^a,b   De Steenhuijsen Piters, Wouter A A ^a,c   Bogaert, Debby ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN;

BACTERIAL COLONIZATION; BACTERIAL FLORA; ENVIRONMENTAL FACTOR; FUNGAL FLORA; HOST PATHOGEN INTERACTION; HUMAN; LOWER RESPIRATORY TRACT; LUNG LAVAGE; MICROBIAL COMMUNITY; MICROFLORA; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RESPIRATORY SYSTEM; REVIEW; UPPER RESPIRATORY TRACT; BACTERIUM; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SYMBIOSIS; VIROLOGY;

BACTERIA; HUMANS; MICROBIOTA; RESPIRATORY SYSTEM; SYMBIOSIS;

EID: 85015657548     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2017.14     Document Type: Review

References (187)

1. Lloyd-Price, J., Abu-Ali, G. & Huttenhower, C. The healthy human microbiome. Genome Med. 8, 51 (2016).
2. Weibel, E. R. Morphometry of the Human Lung (Springer Berlin Heidelberg, 1963).
3. Bogaert, D., De Groot, R. & Hermans, P. W. M. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4, 144-154 (2004).
4. Bäumler, A. J. & Sperandio, V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535, 85-93 (2016).
5. Yun, Y. et al. Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture. PLoS ONE 9, e113466 (2014).
6. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493 (2012).
7. Gollwitzer, E. S. et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat. Med. 20, 642-647 (2014).
8. Som, P. M. & Naidich, T. P. Illustrated review of the embryology and development of the facial region, part 1: early face and lateral nasal cavities. Am. J. Neuroradiol. 34, 2233-2240 (2013).
9. Herriges, M. & Morrisey, E. E. Lung development: orchestrating the generation and regeneration of a complex organ. Development 141, 502-513 (2014).
10. German, R. Z. & Palmer, J. B. Anatomy and development of oral cavity and pharynx. GI Motil. Online http://www.nature.com/gimo/contents/pt1/full/gimo5.html (2006).
11. Burri, P. H. Fetal and postnatal development of the lung. Annu. Rev. Physiol. 46, 617-628 (1984).
12. Wostmann, B. S. The germfree animal in nutritional studies. Annu. Rev. Nutr. 1, 257-279 (1981).
13. + cells. Immunity 17, 31-40 (2002).
14. Aagaard, K. et al. The placenta harbors a unique microbiome. Sci. Transl Med. 6, 237ra65 (2014).
15. Collado, M. C., Rautava, S., Aakko, J., Isolauri, E. & Salminen, S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep. 6, 23129 (2016).
16. Lauder, A. P. et al. Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota. Microbiome 4, 29 (2016).
17. Gomez de Agüero, M. et al. The maternal microbiota drives early postnatal innate immune development. Science 351, 1296-1302 (2016).
18. Koch, M. A. et al. Maternal IgG and IgA antibodies dampen mucosal T helper cell responses in early life. Cell 165, 827-841 (2016).
19. Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107, 11971-11975 (2010).
20. Bosch, A. A. et al. Development of upper respiratory tract microbiota in infancy is affected by mode of delivery. EBioMedicine 9, 336-345 (2016).
21. Biesbroek, G. et al. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am. J. Respir. Crit. Care Med. 190, 1283-1292 (2014).
22. Teo, S. M. et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 17, 704-715 (2015).
23. Biesbroek, G. et al. The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am. J. Respir. Crit. Care Med. 190, 298-308 (2014).
24. Duijts, L., Jaddoe, V. W. V., Hofman, A. & Moll, H. A. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics 126, e18-e25 (2010).
25. Schanche, M. et al. High-resolution analyses of overlap in the microbiota between mothers and their children. Curr. Microbiol. 71, 283-290 (2015).
26. Jeurink, P. V. et al. Human milk: a source of more life than we imagine. Benef. Microbes 4, 17-30 (2013).
27. Hicks, L. A., Taylor, T. H. & Hunkler, R. J. U.S. outpatient antibiotic prescribing, 2010. N. Engl. J. Med. 368, 1461-1462 (2013).
28. Prevaes, S. M. et al. Development of the nasopharyngeal microbiota in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 193, 504-515 (2016).
29. Pettigrew, M. M. et al. Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl. Environ. Microbiol. 78, 6262-6270 (2012).
30. Leibovitz, E. et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr. Infect. Dis. J. 22, 209-216 (2003).
31. Bogaert, D. et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS ONE 6, e17035 (2011).
32. Bogaert, D. et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363, 1871-1872 (2004).
33. Mika, M. et al. Dynamics of the nasal microbiota in infancy: a prospective cohort study. J. Allergy Clin. Immunol. 135, 905-912.e11 (2015).
34. Spijkerman, J. et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS ONE 7, e39730 (2012).
35. Greenberg, D. et al. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin. Infect. Dis. 42, 897-903 (2006).
36. Liu, C. M. et al. Staphylococcus aureus and the ecology of the nasal microbiome. Sci. Adv. 1, e1400216 (2015).
37. Lim, M. Y. et al. Analysis of the association between host genetics, smoking, and sputum microbiota in healthy humans. Sci. Rep. 6, 23745 (2016).
38. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
39. Stearns, J. C. et al. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. ISME J. 9, 1246-1259 (2015).
40. Jakobsson, H. E. et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5, e9836 (2010).
41. Charlson, E. S. et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS ONE 5, e15216 (2010).
42. Morris, A. et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 187, 1067-1075 (2013).
43. Whelan, F. J. et al. The loss of topography in the microbial communities of the upper respiratory tract in the elderly. Ann. Am. Thorac. Soc. 11, 513-521 (2014).
44. Vissing, N. H., Chawes, B. L. K. & Bisgaard, H. Increased risk of pneumonia and bronchiolitis after bacterial colonization of the airways as neonates. Am. J. Respir. Crit. Care Med.188, 1246-1252 (2013).
45. Dominguez-Bello, M. G. et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat. Med. 22, 250-253 (2016).
46. Frank, D. N. et al. The human nasal microbiota and Staphylococcus aureus carriage. PLoS ONE 5, e10598 (2010).
47. Oh, J. et al. Biogeography and individuality shape function in the human skin metagenome. Nature 514, 59-64 (2014).
48. Zhou, Y. et al. Exploration of bacterial community classes in major human habitats. Genome Biol. 15, R66 (2014).
49. Wos-Oxley, M. L. et al. Exploring the bacterial assemblages along the human nasal passage. Environ. Microbiol. 18, 2259-2271 (2016).
50. Yan, M. et al. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe 14, 631-640 (2013).
51. Segata, N. et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 13, R42 (2012).
52. de Steenhuijsen Piters, W. A. et al. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J. 10, 97-108 (2016).
53. van den Bergh, M. R. et al. Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLoS ONE 7, e47711 (2012).
54. Wang, Y. et al. Metagenomic analysis of viral genetic diversity in respiratory samples from children with severe acute respiratory infection in China. Clin. Microbiol. Infect. 22, 458.e1-458.e9 (2016).
55. Wylie, K. M., and Mihindukulasuriya, K. A., Sodergren, E., Weinstock, G. M. & Storch, G. A. Sequence analysis of the human virome in febrile and afebrile children. PLoS ONE 7, e27735 (2012).
56. Eidi, S. et al. Nasal and indoors fungal contamination in healthy subjects. Health Scope 5, e30033 (2016).
57. Charlson, E. S. et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am. J. Respir. Crit. Care Med. 186, 536-545 (2012).
58. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
59. Cardinale, B. J. et al. Biodiversity loss and its impact on humanity. Nature 486, 59-67 (2012).
60. Huttenhower, C., Kostic, A. D. & Xavier, R. J. Inflammatory bowel disease as a model for translating the microbiome. Immunity 40, 843-854 (2014).
61. Kampmann, C., Dicksved, J., Engstrand, L. & Rautelin, H. Composition of human faecal microbiota in resistance to Campylobacter infection. Clin. Microbiol. Infect. 22, 61.e1-61.e8 (2016).
62. Fredricks, D. N., Fiedler, T. L. & Marrazzo, J. M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899-1911 (2005).
63. Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680-4687 (2011).
64. DiGiulio, D. B., and Stevenson, D. K., Shaw, G., Lyell, D. J. & Relman, D. A. Reply to Keelan and Payne: microbiota-related pathways for preterm birth. Proc. Natl Acad. Sci. USA 112, E6415 (2015).
65. Hilty, M. et al. Nasopharyngeal microbiota in infants with acute otitis media. J. Infect. Dis. 205, 1048-1055 (2012).
66. Abreu, N. A. et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci. Transl Med. 4, 151ra124 (2012).
67. Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789-799 (2014).
68. Bomar, L., and Brugger, S. D., Yost, B. H., Davies, S. S. & Lemon, K. P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio 7, e01725-15 (2016).
69. Laufer, A. S. et al. Microbial communities of the upper respiratory tract and otitis media in children. mBio 2, e00245-10 (2011).
70. Kamada, N., and Chen, G. Y., Inohara, N. & Núñez, G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685-690 (2013).
71. Iwase, T. et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465, 346-349 (2010).
72. Lysenko, E. S. et al. Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing. PLoS Pathog. 3, e118 (2007).
73. Huxley, E. J., Viroslav, J., Gray, W. R. & Pierce, A. K. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am. J. Med. 64, 564-568 (1978).
74. Bassis, C. M. et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio 6, e00037-15 (2015).
75. Segal, L. N. et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1, 19 (2013).
76. Marsh, R. L. et al. The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. Microbiome 4, 37 (2016).
77. Lohmann, P. et al. The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia. Pediatr. Res. 76, 294-301 (2014).
78. Payne, M. S. et al. Molecular microbiological characterization of preterm neonates at risk of bronchopulmonary dysplasia. Pediatr. Res. 67, 412-418 (2010).
79. Mourani, P. M., and Harris, J. K., Sontag, M. K., Robertson, C. E. & Abman, S. H. Molecular identification of bacteria in tracheal aspirate fluid from mechanically ventilated preterm infants. PLoS ONE 6, e25959 (2011).
80. Dickson, R. P. et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann. Am. Thorac. Soc. 12, 821-830 (2015).
81. Abbas, A. A. et al. The perioperative lung transplant virome: torque teno viruses are elevated in donor lungs and show divergent dynamics in primary graft dysfunction. Am. J. Transplant. http://dx.doi.org/10.1111/ajt.14076 (2016).
82. Willner, D. et al. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS ONE 4, e7370 (2009).
83. Young, J. C. et al. Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients. Am. J. Transplant. 15, 200-209 (2015).
84. van Woerden, H. C. et al. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect. Dis. 13, 69 (2013).
85. Cleland, E. J. et al. The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes. Int. Forum Allergy Rhinol. 4, 259-265 (2014).
86. Charlson, E. S. et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184, 957-963 (2011).
87. Venkataraman, A. et al. Application of a neutral community model to assess structuring of the human lung microbiome. mBio 6, e02284-14 (2015).
88. Willner, D. et al. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J. 6, 471-474 (2012).
89. Mashima, I. & Nakazawa, F. The influence of oral Veillonella species on biofilms formed by Streptococcus species. Anaerobe 28, 54-61 (2014).
90. Cook, L. C., LaSarre, B. & Federle, M. J. Interspecies communication among commensal and pathogenic streptococci. mBio 4, e00382-13 (2013).
91. Armbruster, C. E. et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio 1, e00102-10 (2010).
92. Wos-Oxley, M. L. et al. A poke into the diversity and associations within human anterior nare microbial communities. ISME J. 4, 839-851 (2010).
93. Regev-Yochay, G., Trzcinski, K., and Thompson, C. M., Malley, R. & Lipsitch, M. Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J. Bacteriol. 188, 4996-5001 (2006).
94. Selva, L. et al. Killing niche competitors by remote-control bacteriophage induction. Proc. Natl Acad. Sci. USA 106, 1234-1238 (2009).
95. Deasy, A. M. et al. Nasal inoculation of the commensal Neisseria lactamica inhibits carriage of Neisseria meningitidis by young adults: a controlled human infection study. Clin. Infect. Dis. 60, 1512-1520 (2015).
96. Janek, D., Zipperer, A., Kulik, A., Krismer, B. & Peschel, A. High frequency and diversity of antimicrobial activities produced by nasal Staphylococcus strains against bacterial competitors. PLoS Pathog. 12, e1005812 (2016).
97. Ramsey, M. M., and Freire, M. O., Gabrilska, R. A., Rumbaugh, K. P. & Lemon, K. P. Staphylococcus aureus shifts toward commensalism in response to Corynebacterium species. Front. Microbiol. 7, 1230 (2016).
98. Zipperer, A. et al. Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535, 511-516 (2016).
99. Tong, T. T., Mörgelin, M., Forsgren, A. & Riesbeck, K. Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles. J. Infect. Dis. 195, 1661-1670 (2007).
100. de Steenhuijsen Piters, W. A., Sanders, E. A. & Bogaert, D. The role of the local microbial ecosystem in respiratory health and disease. Philos. Trans. R. Soc. B Biol. Sci. 370, 20140294 (2015).
101. Taubenberger, J. K., Reid, A. H. & Fanning, T. G. The 1918 influenza virus: a killer comes into view. Virology 274, 241-245 (2000).
102. Bosch, A. A., Biesbroek, G., Trzcinski, K., Sanders, E. A. M. & Bogaert, D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 9, e1003057 (2013).
103. Sajjan, U., Wang, Q., Zhao, Y., Gruenert, D. C. & Hershenson, M. B. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am. J. Respir. Crit. Care Med. 178, 1271-1281 (2008).
104. Avadhanula, V. et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J. Virol. 80, 1629-1636 (2006).
105. Ramphal, R., and Small, P. M., Shands, J. W., Fischlschweiger, W. & Small, P. A. Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation. Infect. Immun. 27, 614-619 (1980).
106. Siegel, S. J., Roche, A. M. & Weiser, J. N. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16, 55-67 (2014).
107. Pittet, L. A., Hall-Stoodley, L., Rutkowski, M. R. & Harmsen, A. G. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 42, 450-460 (2010).
108. Raza, M. W., and Blackwell, C. C., Elton, R. A. & Weir, D. M. Bactericidal activity of a monocytic cell line (THP-1) against common respiratory tract bacterial pathogens is depressed after infection with respiratory syncytial virus. J. Med. Microbiol. 49, 227-233 (2000).
109. Didierlaurent, A. et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205, 323-329 (2008).
110. Sun, K. & Metzger, D. W. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nat. Med. 14, 558-564 (2008).
111. Robinson, K. M. et al. Influenza A virus exacerbates staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production. J. Infect. Dis. 209, 865-875 (2014).
112. Ni, K. et al. Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection. PLoS ONE 7, e41104 (2012).
113. Wyde, P. R., and Six, H. R., Ambrose, M. W. & Throop, B. J. Muramyl peptides and polyinosinic-polycytodylic acid given to mice prior to influenza virus challenge reduces pulmonary disease and mortality. J. Biol. Response Mod. 9, 98-102 (1990).
114. Sajjan, U. S. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J. 20, 2121-2123 (2006).
115. Gulraiz, F., Bellinghausen, C., Bruggeman, C. A. & Stassen, F. R. Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. FASEB J. 29, 849-858 (2015).
116. Bellinghausen, C. et al. Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection. Respir. Res. 17, 68 (2016).
117. de Steenhuijsen Piters, W. A. A. et al. Nasopharyngeal microbiota, host transcriptome and disease severity in children with respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med. 1104-1115 (2016).
118. Scheiblauer, H., Reinacher, M., Tashiro, M. & Rott, R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J. Infect. Dis. 166, 783-791 (1992).
119. Tashiro, M., Ciborowski, P., Klenk, H.-D., Pulverer, G. & Rott, R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature 325, 536-537 (1987).
120. Short, K. R. et al. Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity. J. Innate Immun. 6, 129-139 (2014).
121. Ichinohe, T. et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl Acad. Sci. USA 108, 5354-5359 (2011).
122. Amit, I. et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326, 257-263 (2009).
123. Abt, M. C. et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158-170 (2012).
124. Pride, D. T., Salzman, J. & Relman, D. A. Comparisons of clustered regularly interspaced short palindromic repeats and viromes in human saliva reveal bacterial adaptations to salivary viruses. Environ. Microbiol. 14, 2564-2576 (2012).
125. Williams, H. T. P. Phage-induced diversification improves host evolvability. BMC Evol. Biol. 13, 17 (2013).
126. Segal, L. N. et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. 1, 16031 (2016).
127. Boase, S. et al. Bacterial-induced epithelial damage promotes fungal biofilm formation in a sheep model of sinusitis. Int. Forum Allergy Rhinol. 3, 341-348 (2013).
128. Diaz, P. I. et al. Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect. Immun. 80, 620-632 (2012).
129. Xu, H. et al. Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell. Microbiol. 16, 214-231 (2014).
130. Briard, B., Heddergott, C. & Latgé, J.-P. Volatile compounds emitted by Pseudomonas aeruginosa stimulate growth of the fungal pathogen Aspergillus fumigatus. mBio 7, e00219 (2016).
131. Roux, D. et al. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit. Care Med. 37, 1062-1067 (2009).
132. Linden, S. K., Sutton, P., Karlsson, N. G., Korolik, V. & McGuckin, M. A. Mucins in the mucosal barrier to infection. Mucosal Immunol. 1, 183-197 (2008).
133. Roy, M. G. et al. Muc5b is required for airway defence. Nature 505, 412-416 (2014).
134. Kiyono, H. & Fukuyama, S. NALT-versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4, 699-710 (2004).
135. + T cells regulate immunoglobulin A selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 41, 152-165 (2014).
136. Sutherland, D. B., Suzuki, K. & Fagarasan, S. Fostering of advanced mutualism with gut microbiota by immunoglobulin A. Immunol. Rev. 270, 20-31 (2016).
137. LeVine, A. M. et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J. Immunol. 165, 3934-3940 (2000).
138. Uehara, A., Fujimoto, Y., Fukase, K. & Takada, H. Various human epithelial cells express functional Tolllike receptors, NOD1 and NOD2 to produce antimicrobial peptides, but not proinflammatory cytokines. Mol. Immunol. 44, 3100-3111 (2007).
139. Kim, D.-Y. et al. The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens. J. Immunol. 186, 4253-4262 (2011).
140. Jahnsen, F. L. et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J. Immunol. 177, 5861-5867 (2006).
141. Kopf, M., Schneider, C. & Nobs, S. P. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16, 36-44 (2014).
142. Hussell, T. & Bell, T. J. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81-93 (2014).
143. Westphalen, K. et al. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 506, 503-506 (2014).
144. Holt, P. G. et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177, 397-407 (1993).
145. Holt, P. G., Schon-Hegrad, M. A. & Oliver, J. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J. Exp. Med. 167, 262-274 (1988).
146. + regulatory T cells and promote airway tolerance. J. Exp. Med. 210, 775-788 (2013).
147. Margulies, M. et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376-380 (2005).
148. Mills, B., Bradley, M. & Dhaliwal, K. Optical imaging of bacterial infections. Clin. Transl Imaging 4, 163-174 (2016).
149. McLoughlin, K., Schluter, J., Rakoff-Nahoum, S., Smith, A. L. & Foster, K. R. Host selection of microbiota via differential adhesion. Cell Host Microbe 19, 550-559 (2016).
150. Liu, L. et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151-2161 (2012).
151. Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1095 (2015).
152. Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621-1624 (2012).
153. Goleva, E. et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am. J. Respir. Crit. Care Med. 188, 1193-1201 (2013).
154. Salter, S. J. et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12, 87 (2014).
155. Biesbroek, G. et al. Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS ONE 7, e32942 (2012).
156. Dickson, R. P. et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat. Microbiol. 1, 16113 (2016).
157. Larsen, J. M. et al. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology 144, 333-342 (2015).
158. Bäckhed, F., Normark, S., Schweda, E. K. H., Oscarson, S. & Richter-Dahlfors, A. Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect. 5, 1057-1063 (2003).
159. Coats, S. R., and Reife, R. A., Bainbridge, B. W., Pham, T. T.-T. & Darveau, R. P. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at Toll-like receptor 4 in human endothelial cells. Infect. Immun. 71, 6799-6807 (2003).
160. Munford, R. S. Sensing Gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect. Immun. 76, 454-465 (2008).
161. Salzman, N. H. et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11, 76-83 (2010).
162. Kao, C.-Y. et al. IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κB signaling pathways. J. Immunol. 173, 3482-3491 (2004).
163. Atarashi, K. et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367-380 (2015).
164. Wang, J. et al. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat. Commun. 4, 2106 (2013).
165. Rice, T. A. et al. Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection. Antiviral Res. 132, 131-140 (2016).
166. Clarke, T. B. et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16, 228-231 (2010).
167. Herbst, T. et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am. J. Respir. Crit. Care Med. 184, 198-205 (2011).
168. Naik, S. et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature 520, 104-108 (2015).
169. Krishnamoorthy, N. et al. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat. Med. 18, 1525-1530 (2012).
170. Rangel-Moreno, J. et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12, 639-646 (2011).
171. Scharschmidt, T. C. et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity 43, 1011-1021 (2015).
172. Virgin, H. W., Wherry, E. J. & Ahmed, R. Redefining chronic viral infection. Cell 138, 30-50 (2009).
173. McGeoch, D. J., Rixon, F. J. & Davison, A. J. Topics in herpesvirus genomics and evolution. Virus Res. 117, 90-104 (2006).
174. Barton, E. S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326-329 (2007).
175. Kim, E. Y. et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633-640 (2008).
176. Mejias, A. et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med. 10, e1001549 (2013).
177. England, R. J., and Homer, J. J., Knight, L. C. & Ell, S. R. Nasal pH measurement: a reliable and repeatable parameter Clin. Otolaryngol. Allied Sci. 24, 67-68 (1999).
178. Brunworth, J. D., Garg, R., Mahboubi, H., Johnson, B. & Djalilian, H. R. Detecting nasopharyngeal reflux: a novel pH probe technique. Ann. Otol. Rhinol. Laryngol 121, 427-430 (2012).
179. Ayazi, S. et al. A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J. Gastrointest. Surg. 13, 1422-1429 (2009).
180. West, J. B. Regional differences in the lung. Chest 74, 426 (1978).
181. Keck, T. & Lindemann, J. Numerical simulation and nasal air-conditioning. GMS Curr. Top. Otorhinolaryngol. Head Neck Surg. http://dx.doi.org/10.3205/cto000072 (2010).
182. Ingenito, E. P. et al. Indirect assessment of mucosal surface temperatures in the airways: theory and tests. J. Appl. Physiol. 63, 2075-2083 (1987).
183. McFadden, E. R. et al. Thermal mapping of the airways in humans. J. Appl. Physiol. 58, 564-570 (1985).
184. Morgan, N. J., and MacGregor, F. B., Birchall, M. A., Lund, V. J. & Sittampalam, Y. Racial differences in nasal fossa dimensions determined by acoustic rhinometry. Rhinology 33, 224-228 (1995).
185. Walsh, J. H. et al. Evaluation of pharyngeal shape and size using anatomical optical coherence tomography in individuals with and without obstructive sleep apnoea. J. Sleep Res. 17, 230-238 (2008).
186. Hatch, T. F Distribution and deposition of inhaled particles in respiratory tract. Bacteriol. Rev. 25, 237-240 (1961).
187. Prussin, A. J. & Marr, L. C. Sources of airborne microorganisms in the built environment. Microbiome 3, 78 (2015).